The approval makes the innovator molecule from Novo Nordisk, the first and only GLP-1 receptor agonist approved in India for the treatment of the disease
Research now recognizes that obesity can contribute to type 2 diabetes, cardiovascular disease, and other serious conditions
One case study found a novel mutation in CPT II (del1737C), an autosomal recessive disease with a distinct phenotype [49]
These prescription medications function by activating GLP-1 receptors and lead to prolonged satiety, reduced food intake, and weight loss
This page covers the standard titration, conservative approaches, microdosing options, and how to adjust if side effects are an issue
Houston, TX I've tried every diet out there